Advertisement

Pallium

, Volume 11, Issue 3, pp 24–25 | Cite as

Buprenorfinepleisters

Meer van hetzelfde of een aanwinst voor pijntherapie?
  • Ben Zylicz
Onderzoek
  • 4 Downloads

Samenvatting

Onlangs is een nieuw pijnstillend middel op de markt verschenen: buprenorfine (BPF). Nieuw? BPF wordt al veertig jaar gemaakt. Tot nu toe was BPF echter uitsluitend beschikbaar als sublinguaal tablet en het werd in deze toedieningsvorm niet veel gebruikt. Sinds kort is het middel beschikbaar als pleister en in deze toedieningsvorm zou BBF wel eens vaker toegepast kunnen worden.

Literatuur

  1. 1.
    Malinoff HL, Barkin RL, Wilson G. Sublingual buprenorphine is effective in the treatment of chronic pain syndrome. Am J Ther. Sep-Oct 2005;12(5):379–384.Google Scholar
  2. 2.
    Sittl R, Nuijten M, Nautrup BP. Patterns of dosage changes with transdermal buprenorphine and transdermal fentanyl for the treatment of noncancer and cancer pain: a retrospective data analysis in Germany. Clin Ther. Aug 2006;28(8):1144–1154.Google Scholar
  3. 3.
    Bliesener N, Albrecht S, Schwager A, Weckbecker K, Lichtermann D, Klingmuller D. Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metab. Jan 2005;90(1):203–206.Google Scholar
  4. 4.
    Sacerdote P. Opioid-induced immunosuppression. Curr Opin Support Palliat Care. Mar 2008;2(1):14–18.Google Scholar
  5. 5.
    Vadivelu N, Hines RL. Management of chronic pain in the elderly: focus on transdermal buprenorphine. Clin Interv Aging. 2008;3(3):421–430.Google Scholar
  6. 6.
    Tassinari D, Sartori S, Tamburini E, et al. Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: a meta-analysis and systematic review of the literature. J Palliat Med. May-Jun 2008;11(3):492–501.Google Scholar
  7. 7.
    Poulain P, Denier W, Douma J, et al. Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain. J Pain Symptom Manage. Aug 2008;36(2):117–125.Google Scholar
  8. 8.
    Pergolizzi J, Boger RH, Budd K, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. Jul-Aug 2008;8(4):287–313.Google Scholar
  9. 9.
    Kress HG. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine. Eur J Pain. Jun 20 2008.Google Scholar

Copyright information

© Bohn Stafleu van Loghum 2008

Authors and Affiliations

  • Ben Zylicz
    • 1
  1. 1.

Personalised recommendations